N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine

C75H92Cl4N18O11S3 — CID 161437440

IUPACN-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine
SMILESCS(=O)(=O)N1CC2CC1CN2c1cc(Cl)cc2[nH]ncc12.CS(=O)(=O)N1CCC(c2cc(N3CCOCC3)cc3[nH]ncc23)CC1.CS(=O)(=O)NC1CCC(c2cc(Cl)cc3[nH]ncc23)CC1.O=C(C1COC1)N1CCC(c2cc(Cl)cc3[nH]ncc23)CC1.O=C(C1COC1)N1CCN(c2cc(Cl)cc3[nH]ncc23)CC1
InChIInChI=1S/C17H24N4O3S.C16H18ClN3O2.C15H17ClN4O2.C14H18ClN3O2S.C13H15ClN4O2S/c1-25(22,23)21-4-2-13(3-5-21)15-10-14(20-6-8-24-9-7-20)11-17-16(15)12-18-19-17;17-12-5-13(14-7-18-19-15(14)6-12)10-1-3-20(4-2-10)16(21)11-8-22-9-11;16-11-5-13-12(7-17-18-13)14(6-11)19-1-3-20(4-2-19)15(21)10-8-22-9-10;1-21(19,20)18-11-4-2-9(3-5-11)12-6-10(15)7-14-13(12)8-16-17-14;1-21(19,20)18-7-9-4-10(18)6-17(9)13-3-8(14)2-12-11(13)5-15-16-12/h10-13H,2-9H2,1H3,(H,18,19);5-7,10-11H,1-4,8-9H2,(H,18,19);5-7,10H,1-4,8-9H2,(H,17,18);6-9,11,18H,2-5H2,1H3,(H,16,17);2-3,5,9-10H,4,6-7H2,1H3,(H,15,16)
InChIKeyVYVJQYLEMIWWIH-UHFFFAOYSA-N
MW1659.69 g/mol
LogP9.85
Rot. Bonds12

About N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine

N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine (PubChem CID 161437440) has the molecular formula C75H92Cl4N18O11S3 and a molecular weight of 1659.69 g/mol. Its IUPAC name is N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine.

Molecular Properties

Compound NameN-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine
PubChem CID161437440
Molecular FormulaC75H92Cl4N18O11S3
Molecular Weight1659.69 g/mol
Exact Mass1656.51
IUPAC NameN-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine
SMILESCS(=O)(=O)N1CC2CC1CN2c1cc(Cl)cc2[nH]ncc12.CS(=O)(=O)N1CCC(c2cc(N3CCOCC3)cc3[nH]ncc23)CC1.CS(=O)(=O)NC1CCC(c2cc(Cl)cc3[nH]ncc23)CC1.O=C(C1COC1)N1CCC(c2cc(Cl)cc3[nH]ncc23)CC1.O=C(C1COC1)N1CCN(c2cc(Cl)cc3[nH]ncc23)CC1
InChIInChI=1S/C17H24N4O3S.C16H18ClN3O2.C15H17ClN4O2.C14H18ClN3O2S.C13H15ClN4O2S/c1-25(22,23)21-4-2-13(3-5-21)15-10-14(20-6-8-24-9-7-20)11-17-16(15)12-18-19-17;17-12-5-13(14-7-18-19-15(14)6-12)10-1-3-20(4-2-10)16(21)11-8-22-9-11;16-11-5-13-12(7-17-18-13)14(6-11)19-1-3-20(4-2-19)15(21)10-8-22-9-10;1-21(19,20)18-11-4-2-9(3-5-11)12-6-10(15)7-14-13(12)8-16-17-14;1-21(19,20)18-7-9-4-10(18)6-17(9)13-3-8(14)2-12-11(13)5-15-16-12/h10-13H,2-9H2,1H3,(H,18,19);5-7,10-11H,1-4,8-9H2,(H,18,19);5-7,10H,1-4,8-9H2,(H,17,18);6-9,11,18H,2-5H2,1H3,(H,16,17);2-3,5,9-10H,4,6-7H2,1H3,(H,15,16)
InChIKeyVYVJQYLEMIWWIH-UHFFFAOYSA-N
XLogP9.85
TPSA342.36 Ų
H-Bond Donors6
H-Bond Acceptors19
Rotatable Bonds12
Heavy Atoms111
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001659.69
LogP ≤ 59.85
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1019

Analyze N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;1-(6-chloro-1H-indazol-4-yl)piperidine-3-carboxamide;6-chloro-4-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indazole
CID 158946055
N-[4-[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]phenyl]methanesulfonamide
CID 146647459
6-chloro-4-(1-methylsulfonylpiperidin-4-yl)-1H-indazole;7-chloro-4-(1-methylsulfonylpiperidin-4-yl)-1H-indazole;1-[4-(1H-indazol-5-yl)piperazin-1-yl]ethanone;7-methyl-4-(1-methylsulfonylpiperidin-4-yl)-1H-indazole
CID 161257438
7-(6-chloro-1H-indazol-4-yl)-1,2,5,6,8,8a-hexahydroimidazo[1,5-a]pyrazin-3-one;5-(6-chloro-1H-indazol-4-yl)-2,3,3a,4,6,7-hexahydro-[1,2]thiazolo[2,3-a]pyrazine 1,1-dioxide;1-[4-(6-chloro-1H-indazol-4-yl)-2-ethylpiperazin-1-yl]ethanone;1-[4-(6-cyclopropyl-1H-indazol-4-yl)piperidin-1-yl]ethanone;6-cyclopropyl-4-(1-methylsulfonylpiperidin-4-yl)-1H-indazole
CID 160876899
1-(6-chloro-1H-indazol-4-yl)-N-methylpiperidine-4-carboxamide
CID 121326810
1-[1-(6-chloro-1H-indazol-4-yl)piperidin-3-yl]ethanone
CID 158303166
4-(1-benzylsulfonylpiperidin-4-yl)-6-chloro-1H-indazole;1-[(2R,6S)-4-(6-chloro-1H-indazol-4-yl)-2,6-dimethylpiperazin-1-yl]ethanone;4-(6-chloro-1H-indazol-4-yl)-N-methylpiperazine-1-sulfonamide;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(1-hydroxycyclopropyl)methanone;N-[1-(6-chloro-1H-indazol-4-yl)piperidin-4-yl]-N-methylmethanesulfonamide
CID 159975102
S-methyl 4-(6-chloro-1H-indazol-4-yl)piperazine-1-carbothioate
CID 146647514
1-[1-(6-chloro-1H-indazol-4-yl)piperidin-3-yl]ethanone;N-[1-(6-chloro-1H-indol-4-yl)pyrrolidin-3-yl]acetamide;6-chloro-4-[(2R)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indole;6-chloro-4-[(2S)-2-methyl-4-methylsulfonylpiperazin-1-yl]-1H-indole
CID 158303164
1-[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-2-fluoro-2-methylpropan-1-one
CID 121326428
6-chloro-4-pyrrolidin-1-yl-1H-indazole
CID 138559858
N-benzyl-1H-indazol-4-amine;6-methyl-4-(4-methylsulfonylpiperazin-1-yl)-1H-indazole;6-methyl-4-(1-methylsulfonylpiperidin-4-yl)-1H-indazole;4-(4-methylsulfonylpiperazin-1-yl)-6-phenyl-1H-indazole;4-(1-methylsulfonylpiperidin-4-yl)-6-phenyl-1H-indazole
CID 162187072

Frequently Asked Questions

What is the IUPAC name of N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine?
The IUPAC name of N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine (CID 161437440) is N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine.
What is the SMILES notation for N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine?
The canonical SMILES for N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine is CS(=O)(=O)N1CC2CC1CN2c1cc(Cl)cc2[nH]ncc12.CS(=O)(=O)N1CCC(c2cc(N3CCOCC3)cc3[nH]ncc23)CC1.CS(=O)(=O)NC1CCC(c2cc(Cl)cc3[nH]ncc23)CC1.O=C(C1COC1)N1CCC(c2cc(Cl)cc3[nH]ncc23)CC1.O=C(C1COC1)N1CCN(c2cc(Cl)cc3[nH]ncc23)CC1.
What is the InChIKey of N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine?
The InChIKey is VYVJQYLEMIWWIH-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H24N4O3S.C16H18ClN3O2.C15H17ClN4O2.C14H18ClN3O2S.C13H15ClN4O2S/c1-25(22,23)21-4-2-13(3-5-21)15-10-14(20-6-8-24-9-7-20)11-17-16(15)12-18-19-17;17-12-5-13(14-7-18-19-15(14)6-12)10-1-3-20(4-2-10)16(21)11-8-22-9-11;16-11-5-13-12(7-17-18-13)14(6-11)19-1-3-20(4-2-19)15(21)10-8-22-9-10;1-21(19,20)18-11-4-2-9(3-5-11)12-6-10(15)7-14-13(12)8-16-17-14;1-21(19,20)18-7-9-4-10(18)6-17(9)13-3-8(14)2-12-11(13)5-15-16-12/h10-13H,2-9H2,1H3,(H,18,19);5-7,10-11H,1-4,8-9H2,(H,18,19);5-7,10H,1-4,8-9H2,(H,17,18);6-9,11,18H,2-5H2,1H3,(H,16,17);2-3,5,9-10H,4,6-7H2,1H3,(H,15,16).
What are the key properties of N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine?
N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine has a molecular weight of 1659.69 g/mol, XLogP of 9.85, 12 rotatable bonds, 6 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-(6-chloro-1H-indazol-4-yl)cyclohexyl]methanesulfonamide;[4-(6-chloro-1H-indazol-4-yl)piperazin-1-yl]-(oxetan-3-yl)methanone;[4-(6-chloro-1H-indazol-4-yl)piperidin-1-yl]-(oxetan-3-yl)methanone;6-chloro-4-(5-methylsulfonyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)-1H-indazole;4-[4-(1-methylsulfonylpiperidin-4-yl)-1H-indazol-6-yl]morpholine is sourced from PubChem (CID 161437440), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).